Skip to main content
logo
HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.300
+0.175 (5.60%)
Sep 18, 2026, 3:55 PM HKT

HighTide Therapeutics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,8851,6856546,671--
Market Cap Growth
-21.05%157.80%-90.20%---
Enterprise Value
1,6971,340738,025--
Last Close Price
3.302.951.2712.96--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
9.324.151.458.62--
P/TBV Ratio
9.784.931.458.62--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.880.350.180.02-2.70-3.72
Net Debt / Equity Ratio
-0.98-1.03-0.97-1.02-0.91-0.91
Net Debt / EBITDA Ratio
0.981.690.931.61-1.91-1.88
Net Debt / FCF Ratio
-2.251.362.01-2.49-2.69
Quick Ratio
2.915.274.479.320.6426.85
Current Ratio
3.285.424.679.760.6527.17
Return on Equity (ROE)
-105.14%-58.85%-67.76%-808.89%--
Return on Assets (ROA)
-24.24%-25.15%-41.03%-33.94%-17.29%-
Return on Capital Employed (ROCE)
-66.10%-49.30%-98.80%-62.70%48.70%-17.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.58%-16.17%-62.15%-15.51%--
FCF Yield
--11.03%-49.28%-5.90%--
Buyback Yield / Dilution
-12.36%-6.12%-74.08%-1.91%-506.17%-